How Do Oncogenes Influence Prognosis in Pediatric Cancer Patients?
The presence of certain oncogenes can significantly influence the prognosis of pediatric cancer patients. For example, MYCN amplification in neuroblastoma is often associated with poor prognosis and aggressive disease. Conversely, the identification of specific oncogenes can also lead to more personalized and effective treatment plans, potentially improving outcomes. Thus, understanding the role of oncogenes is crucial for both prognosis and treatment planning.
